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ABSTRACT
Objectives: Endocervical curettage (ECC) together with the dilatation and curettage of the uterine cavity (D & C) is routinely 
performed in everyday clinical practice. The aim of this study is to assess the rationale of the performance of ECC prior to 
D & C in indications other than abnormal uterine bleeding (AUB).
Material and methods: Case histories of 736 patients after ECC performed in the 1st Department of Obstetrics and Gynae-
cology, Medical University of Warsaw, were analyzed retrospectively, the indications for the procedure — age, menopausal 
status, parity, procedure operator’s experience — as well as the result of the histopathology examination were taken into 
account. Three groups of patients were distinguished based on the indications for the procedure.
Results: In 645 (87.6%) of cases normal histopathology results were obtained. 40 (5.4%) cases were abnormal. 31 cases of 
uterine cervix dysplasia were disclosed (CIN 1–20; CIN 2–5; CIN 3–6), 8 cases of endometrial cancer and 1 case of cancer 
of the uterine cervix were disclosed. In 51 (7%) of cases tissue material for histopathology examination was not obtained. 
In patients where ECC and D & C were performed due to indications other than abnormal bleeding from uterine cavity, 
no abnormal results were revealed. In addition, in this group the highest number of non-diagnostic ECCs was reported 
(11.59%; p < 0.05).
Conclusions: In the case of endometrial biopsy for indications other than AUB routine ECC prior to D & C need not be 
performed.
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INTRODUCTION
The curettage of the uterine cervix canal (endocervical 
curettage, ECC) is a procedure allowing to sample tissue 
material for histopathology examination. It is considered 
by many gynaecologists to be an indispensable element of 
the colposcopic assessment allowing to exclude non-symp-
tomatic cases of dysplasia/cancer of the uterine cervix and 
should be performed in all non-pregnant women, irrespec-
tive of age or cytology result [1, 2]. A routine ECC during 
colposcopy (irrespective of its result) increases its sensitivity. 
It was pointed out that 2–6% of high-grade dysplasia as well 
as uterine cervix cancer are detected solely thanks to the 
ECC [3, 4]. According to some authors ECC should be per-
formed only in case of abnormal cytology results or unsat-
isfactory colposcopy [5, 7].
In spite of the broad application of outpatient tech-
niques of endometrial biopsy, dilatation and curettage of 
the uterine cavity (D & C) in numerous situations remains 
the principal diagnostic method [8]. In everyday clinical 
practice D & C is routinely performed together with ECC. 
The advantage of D & C over other less invasive methods 
of endometrial biopsy (Pipella, tao brush, vacuum biop-
sy) is often emphasized, the possibility of a simultaneous 
sampling of material from the uterine cervix canal being 
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indicated. Indications for D & C and ECC include abnormal 
uterine bleeding (AUB), an abnormal picture of the endo-
metrium on USG examination, a suspicion of an endometrial 
polyp, check-ups after endometrial hyperplasia treatment 
as well as non-diagnostic biopsies with low-invasive tech-
niques. While in the case of abnormal bleedings from the 
birth canal a combined performance of ECC and D & C 
arouses no doubts, routine ECC during D & C in the case of 
other indications remains a controversial procedure.
OBJECTIVES
The aim of the study is the assessment of the rationale 
of the performance of ECC prior to D & C in the case of 
indications other than abnormal bleedings.
MATERIAL AND METHODS
Case histories of 736 patients after ECC performed in 
the 1st Department of Obstetrics and Gynaecology, Medical 
University of Warsaw, between January 2002 and November 
2004 were analyzed retrospectively. Based on the indications 
for the ECC procedure, the patients were divided into three 
groups. In 287 of cases the indication for ECC was a suspi-
cion of cervical dysplasia including an abnormal cytology 
result (ASC-US, ASC-H, L-SIL, H-SIL) or unsatisfactory/ab-
normal colposcopy. The second group covered 285 women 
in whom ECC was performed together with D & C due to 
abnormal bleedings from the uterine cavity. The last group 
were 164 women in whom ECC together with D & C was 
performed for reasons other than abnormal bleedings from 
the birth canal i.e.: an abnormal picture of the endome-
trium on USG examination, a suspicion of an endometrial 
polyp, check-up after endometrial hyperplasia treatment 
or non-diagnostic endometrial biopsies with low-invasive 
techniques.
An analysis was conducted of the following factors of 
potential influence on obtaining adequate histopathology 
material: age, menopausal status, parity and experience of 
the procedure-performing operator.
The mean age of patients covered by the study was 
49.87 yrs (18–86 yrs). Post-menopausal women and men-
struating women constituted 41.44% (305/736) and 58.66% 
(431/736), respectively. The study population included 
20.92% (152/736) of nulliparas. 12 doctors in the course of 
specialty training performed 61% (449/736) of the proce-
dures. The remaining procedures, i.e. 39% (287/736), were 
performed by 10 specialists in the field of obstetrics and 
gynaecology. A detailed characteristics of the study groups 
of women is given in Table 1.
Examination technique
ECC was performed with the use of sharp metal, size 
#2 curettes. Prior to the commencement of the procedure 
sterile swabs were placed in the lower speculum so as not to 
lose small scrapings from the uterine cervix canal. The ante-
rior lip of the uterine cervix was captured with a vulsella and 
pulled downwards. Next, each of the four quadrants of the 
canal were scraped out. In the case of patients undergoing 
endometrial sampling, ECC was always performed before 
D & C to prevent mixing up specimen from the uterine cavity 
with the tissue from the cervical canal.
The following abnormal histopathology results were 
revealed on ECC: dysplasia of the uterine cervix, cervical 
cancer, endometrial cancer. The normal results were adopted 
to include: normal texture of the mucous membrane of the 
uterine cervix canal, metaplasia of the epithelium of the 
uterine cervix canal, inflammation of the uterine cervix canal.
The statistical analysis was conducted in Statistica 
12 software. In the analysis of measurable data student t-test 
was used, in the absence of normality the Mann-Whitney 
U test was used. To evaluate the dependence of qualitative 
variables chi-square test was used. A statistical significance 
level of 0.05 was adopted.
Table 1. Characteristics and comparison of analyzed groups
Groups Indications for ECC
Number of 
women
(all n = 736)
Mean age Post-menopausal women Nulliparas
Procedures performed by 
doctors in the course of 
training
Group No. 1
Other than abnormal 
bleedings  
(together with D & C)
164 56.79 (26–86) 107 (65%) 26 (15.85%) 103 (62.8%)
Group No. 2 Abnormal bleedings (together with D & C) 285 51.21 (23–86) 136 (47.7%) 46 (16.19%) 183 (64%)
Group No. 3 Suspicion of uterine cervix dysplasia 287 41.61 (18–75) 62 (21.6%) 82 (28.57%) 163 (56%)
Statistical difference between groups in analyzed 
variables (age, menopausal status, parity, doctor’s 
experience)
p < 0.05 p < 0.05 p < 0.05 p > 0.05
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RESULTS
40 (5.4%) out of the 736 results of scrapings from the 
uterine cervix canal were abnormal. 31 cases of uterine 
cervix dysplasia (CIN 1–20; CIN 2–5; CIN 3–6), 8 cases of 
endometrial cancer and 1 case of uterine cervix cancer were 
disclosed. In 645 (87.6%) of cases normal histopathology 
results were obtained: (538 — normal mucous membrane 
of the uterine cervix canal, 68 — metaplasia of the uterine 
cervix canal; 39 — inflammation of epithelium of the uter-
ine cervix canal). In 51 (7%) of cases no tissue material was 
obtained for histopathology examination (mucus, blood). 
Table 2 presents the results of the histopathology examina-
tion of scrapings from the uterine cervix canal according to 
indications for ECC.
Almost all diagnoses of uterine cervix dysplasia (29/31; 
93.55%) were obtained in the group of women in which 
a suspicion of cervical intraepithelial neoplasia was an indi-
cation for ECC (Figure 1). Two cases of uterine cervix dyspla-
sia were diagnosed in the course of procedures performed 
due to abnormal bleedings from the birth canal with simul-
taneous normal results from uterine cavity scrapings. The 
only case of an invasive uterine cervix cancer was reported 
in the group with a suspicion of uterine cervix dysplasia.
8 cases of endometrial cancel were disclosed in scrap-
ings from the uterine cervix canal. In all these cases the 
indication for the procedure involved abnormal bleedings 
from the birth canal. In 7 of them identical cells were present 
in the scrapings from the uterine cavity. In one case, abra-
sion of the uterine cavity revealed purulent and atrophic 
foci without neoplastic cells. In this case, the diagnosis of 
endometrial cancer was based on ECC.
Scrapings from the uterine cervix canal in the group of 
women subjected to ECC for indications other than AUB did 
not produce any abnormal histopathology results.
A statistically significant difference was found between 
the analyzed patient groups in terms of the frequency of 
failure to obtain material from the uterine cervix canal 
(p < 0.05). The highest number of non-diagnostic biop-
sies was registered among patients who underwent ECC 
together with D & C from indications other than abnormal 
bleedings from the birth canal — 19/164 (11.59%). Fewer 
non-diagnostic biopsies were performed in the group of 
patients with abnormal bleedings from the birth canal 
— 23/285 (8.07%) as well as in patients with a suspicion of 
uterine cervix dysplasia 9/287 (3.14%).
The age of the patients proved to be a factor of essential 
influence on obtaining diagnostic material in all groups. Si-
multaneously, the menopausal status and the experience of 
the doctor performing the procedure were essential factors 
in women with a suspicion of dysplasia as well as in patients 
Table 2. Abnormal histopathological results
Groups Indications for ECC Dysplasia (n = 31)
Uterine cervix 
cancer (n = 1)
Endometrial 
cancer (n = 8)
Absence  
of material
Group No. 1 
(n = 164)
Other than abnormal bleedings 
(together with D & C) 0 0 0 19 (11.59%)
Group No. 2 
(n = 285)
Abnormal bleedings  
(together with D & C) 2 (0.7%) 0 8 (2.8%) 23 (8.07%)
Group No. 3 
(n = 287) Suspicion of uterine cervix dysplasia 29 (10.45%) 1 (0.3%) 0 9 (3.14%)
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Figure 1. Abnormal histopathological results
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with abnormal bleedings from the birth canal. No relation 
was found between absence of a history of past labours and 
a higher percentage of non-diagnostic biopsies (Table 3).
DISCUSSION
ECC is used first and foremost in the diagnosis of dys-
plasia of the epithelium of the uterine cervix canal and 
abnormal bleedings from the birth canal. However, in every-
day clinical practice this procedure is very often performed 
together with D & C regardless of the presence of a suspicion 
of a pathology within the uterine cervix canal. A variety of 
reasons have been given in support of this approach.
Firstly, it is argued that the sensitivity of cytological 
smears in the detection of uterine cervix dysplasia is un-
satisfactory. Older publications estimate the sensitivity 
and specificity of cytology at 80–94% and 99%, respective- 
ly [9, 10]. In a Canadian study covering over 10 000 of wo- 
men, the sensitivity of cytology was reported to be 55.4%, 
with a specificity of 96.8% [11]. Studies conducted over the 
past few years indicate a sensitivity of 57–58% and specificity 
of 63–76% [12, 13]. In one of the largest studies dealing with 
the primary prophylaxis of cancer of the uterine cervix car-
ried out in North America and Europe, over 60 000 women 
were examined and the sensitivity and specificity of cytol-
ogy were estimated at 53% and 96.3%, respectively [14]. 
Numerous studies assessed also the sensitivity and specific-
ity of ECC. It amounts to 49–82% and 75–97%, respectively 
[15–18]. What is also indicated is a high percentage of false 
negative and false positive results of ECC amounting to 45% 
and 25%, respectively [15]. A direct comparison was also 
made of ECC with cytology in a follow-up in women after 
the treatment of uterine cervix dysplasia which revealed 
the superiority of cytology [1, 19]. ASCCP recommendations 
with respect to the collection of material from the uterine 
cervix canal include both the brush and the traditional bi-
opsy (ECC) [20]. Attention was however drawn to the higher 
sensitivity with similar specificity, better tolerance as well 
as lower percentage of non-diagnostic attempts obtained 
with the use of the brush technique.
The unsatisfactory quality of cytology can result from 
the absence of endocervix cells in the smear. It was found 
out that abnormal results were more common in smears 
containing endocervix cells than in smears without endo-
cervix cells [21, 22]. Following these studies, the assessment 
of endocervix cells became a standard as it was believed to 
increase the chance of detecting abnormalities. Yet, later 
studies failed to prove that the presence of endocervix cells 
guarantees the detection of abnormalities [23–26]. A large 
study covering approximately 50 000 patients showed that 
absence of endocervix cells in a smear is not linked to an in-
creased risk of abnormalities in subsequent smears [26]. 
These results tend to be explained with a thesis that ab-
normal cells in the cervical canal are more weakly attached 
to the matrix and thus easier to be sampled. Consequently, 
the performance of ECC in the absence of endocervix cells 
in normal cytological smears is unjustified.
Secondly, in countries with a low percentage of women 
having cytology regularly (in Poland, in the years 2007–2009, 
only 24% of women took part in the uterine cervix cancer pro-
phylaxis programme [27]), ECC might be treated as an element 
of screening for uterine cervix cancer increasing the number 
of women under oncologic monitoring and giving a chance 
to detect abnormalities within the canal epithelium. However, 
ECC alone does not give a complete picture of the condition 
Table 3. Comparison of diagnostic ECC vs. non-diagnostic ECC
Group Variables Diagnostic ECC Non-diagnostic ECC 
Statistical 
significance
Indications other 
than AUB
Mean age 55.5 59 p < 0.05
Post-menopausal women 94/145 (64.8%) 12/19 (63%) p > 0.05
Procedures performed by doctors in the course of 
training 92/145 (63.4%) 13/19 (68%) p > 0.05
Nulliparas 26/145 (17.93%) 0 p < 0.05
AUB
Mean age 50,5 59 p < 0.05
Post-menopausal women 118/262 (45.04%) 18/23 (78.26%) p < 0.05
Procedures performed by doctors in the course of 
training 165/262 (62.98%) 18/23 (78.26%) p < 0.05
Nulliparas 43/262 (16.41%) 3/23 (13.04%) p > 0.05
Dysplasia of the 
uterine cervix
Mean age 39.9 48.5 p < 0.05
Post-menopausal women 69/278 (24.82%) 6/9 (66.66%) p < 0.05
Procedures performed by doctors in the course of 
training 159/278 (57.19%) 5/9 (55.55%) p > 0.05
Nulliparas 79/278 (28.41%) 3/9 (33.33%) p > 0.05
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of the uterine cervix and cannot be treated as a substitute of 
cytology. A normal result can give the patient a feeling of false 
security simultaneously encouraging the gynaecologist to 
resign from the performance of a check-up cytology.
The performance of ECC together with D & C can also 
result from the fear of a possible presence of an occult (as-
ymptomatic) cancer of the uterine cervix. Yet, the sensitivity 
of ECC in the detection of abnormalities within both the 
squamous and the glandular epithelium is too low. Ander-
sen et al. showed that ECC fails to detect 45% of changes in 
the squamous epithelium present in the cervical canal [15]. 
In turn, two studies evaluating ECC in terms of the detection 
of abnormal changes in the glandular epithelium sensitiv-
ity were found to be at the level of 43% and 35% [28, 29]. 
Irvin et al. proved that failure to perform ECC in women 
with an abnormal cytology result will not result in failure to 
diagnose an invasive or micro-invasive cancer of the uterine 
cervix. Moreover, in this study, the only case of an invasive 
cancer of the uterine cervix was detected in a patient with 
a normal ECC result [30].
Abnormal bleedings from the birth canal, in particular 
in post-menopausal women, can be the first sign of endo-
metrial cancer [31]. In menstruating women, they can be 
indicative of dysplasia/cancer of the uterine cervix [32]. 
Therefore, in the case of abnormal bleedings from the birth 
canal, ECC should always be performed together with D & C. 
Our study also confirms the necessity of performing ECC 
together with D & C in the case of abnormal bleedings from 
the birth canal. In 2 cases abnormal bleedings were caused 
by dysplasia of the epithelium of the uterine cervix canal.
What deserves particular attention, however, is one of 
the cases of endometrial cancer. The material sampled from 
the uterine cavity contained purulent and atrophic foci 
without cancer cells while tumour tissue texture was present 
only in the scrapings from the uterine cervix canal. Failure to 
perform ECC in this case would at best have caused a delay 
in diagnosis and at worst it could have resulted in missing 
the presence of endometrial cancer.
The performance of ECC together with D & C in the case 
of indications other than abnormal bleedings from the birth 
canal is a controversial procedure. This results also from our 
study. In 164 cases not a single abnormal result was found. 
What was reported, however, was the highest percentage 
of non-diagnostic biopsies. Other works showed that in 
2.5–28% of cases ECC fails to produce diagnosis due to too 
small or inadequate material for histopathology examina-
tion [15–17, 33]. The main drawback of this procedure seems 
to be the high percentage of non-diagnostic results.
The principal limitation of the present study is its retro-
spective character as well as the relatively small size of the 
study group. In order to formulate unequivocal recommen-
dations it is necessary to conduct a prospective study with 
significantly more numerous groups of women selected in 
terms of age and menopausal status. Simultaneously, to 
confirm the impact of the experience of the ECC-performing 
doctor a randomized assignment of a doctor to a patient 
should be made.
CONCLUSIONS
ECC is the gold standard in the diagnostics of endo-
cervix pathologies. Routine performance of ECC prior to 
D & C is justified primarily in the diagnostics of abnormal 
bleedings from the birth canal. Simultaneously, in the case 
of endometrial biopsy due to indications other than AUB, 
ECC need not be performed prior to D & C, in particular in 
post-menopausal patients and in patients with a non-con-
tributory cytological history.
The efficacy of ECC in obtaining tissue material depends 
on indications for the procedure and the age of the patient. 
Additional factors of potential influence on ECC include: 
parity, menopausal status and experience of the proce-
dure-performing doctor.
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